Latest Mammaprint Stories
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer.
As a woman ages, her chances of being diagnosed with a lower-risk breast tumor increase.
IRVINE, California and AMSTERDAM, August 10, 2011 /PRNewswire/ -- Agendia, a commercial-stage molecular cancer diagnostics company, today announced that the 12th St.
- The governor of a province or people.